NNVC Stock Summary and Trading Ideas (Nanoviricides | AMEX:NNVC)

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Nanoviricides trades on the AMEX stock market under the symbol NNVC.

As of December 17, 2025, NNVC stock price declined to $1.24 with 239,665 million shares trading.

NNVC has a beta of 0.29, meaning it tends to be less sensitive to market movements. NNVC has a correlation of 0.01 to the broad based SPY ETF.

NNVC has a market cap of $26.74 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, NNVC traded as high as $3.59 and as low as $.94.

The top ETF exchange traded funds that NNVC belongs to (by Net Assets): VTI, VXF.

NNVC has underperformed the market in the last year with a return of -16.8%, while the SPY ETF gained +12.3%. In the last 3 month period, NNVC fell short of the market, returning -13.9%, while SPY returned +2.1%. However, in the most recent 2 weeks NNVC has outperformed the stock market by returning +11.7%, while SPY returned -1.8%.

NNVC support price is $1.20 and resistance is $1.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NNVC shares will trade within this expected range on the day.